Nautilus Biotech

Nautilus Biotech proprietary Platform Biomics™ technology uniquely blends viral, genetic diversity and bio-modeling technologies within a high-throughput infrastructure for the directed evolution of bio-molecules, and for applications in functional genomics and cell-line engineering.
Nautilus Biotech leverages its technology by providing our partners unparalleled directed evolution and screening opportunities as well as for constructing optimized products for bio-pharmaceutical (therapeutic proteins, vaccines, antibodies) or industrial (e.g., enzymes, R&D reagents) commercial opportunities.

Activity:

- Research & Development
- Other Industry Services

Product / Technology type(s) covered:

- Bio
- Cosmoceuticals
- Curative
- Diagnostics
- Enzymes
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Proteins
- Reagents
- Technology

Therapeutic targets:

- Diabetes
- Infectious Diseases
- Obesity
- Oncology
- Pain

Markets Covered

a. HeadQuarter: France

b. Continent(s) active: North America , Europe , Asia , Far East , Australia/New-Zealand , Central/South America , Near/Middle East , Africa

c. Countries active: US, Germany, UK, France

Corporate data:

Number of Employees: 31

Turnover:

Amount:	Year:	Currency:
000	2001	Euro

Year founded: 1999